Neurothera Labs Inc. (TSXV:NTLX) entered into a binding term sheet to acquire Portfolio of patents, trademarks, know-how of Xylo Technologies Ltd on November 26, 2025. On January 8, 2026, SciSparc Ltd. (NasdaqCM:SPRC) entered into a definitive agreement to acquire Portfolio of patents, trademarks, know-how of Xylo Technologies Ltd. The consideration consists of issue to Xylo an amount of ordinary shares of the SciSparc, which shall represent as of the closing date, 19.99% of the issued and outstanding share capital of the SciSparc. As part of consideration, an undisclosed value is paid towards assets of Portfolio of patents, trademarks, know-how of Xylo Technologies Ltd. The closing of the transaction will be subject to customary closing conditions, including receipt of shareholder approval, required regulatory approvals, negotiating and signing definitive agreements for the acquisition and is expected to close on March 8, 2026.

Meytal Katz of Primes & Co. acted as legal advisor for Xylo Technologies. Shachar Hadar of Meitar acted as legal advisor for SciSparc Ltd.